Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease

Cancer

Volumn 85, Issue 1, 1999, Pages 178-187

  Kraft, Andrea ^a   Weindel, Karin ^a   Ochs, Andreas ^b   Marth, Christian ^c   Zmija, Jörg ^a   Schumacher, Petra ^a   Unger, Clemens ^a   Marmé, Dieter ^a   Gastl, Günther ^a,d  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Angiogenesis; Ascites; Cancer; Effusion; Metastasis; Serum; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ASCITES; BREAST CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; EFFUSION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL CARCINOMA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; OVARY CARCINOMA; PRIORITY JOURNAL; SERUM; TUMOR GROWTH;

ADULT; AGED; ASCITIC FLUID; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INFECTION; LIVER CIRRHOSIS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; OVARIAN NEOPLASMS; PLEURAL EFFUSION; PROGNOSIS; STOMACH NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032944081     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7     Document Type: Article

References (35)

1. Folkman I, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339:58-61.
2. Folkman J. Endothelial cells and angiogenic growth factors in cancer growth and metastasis. Introduction. [Review.] Cancer Metastasis Rev 1990;9:171-4.
3. Folkman J. The role of angiogenesis in tumor growth [review]. Semin Cancer Biol 1992;3:65-71.
4. Weidner N, Folkman J, Pozza F, Bevilaqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
5. Bossi P, Viale G, Lee AK, Alfano R, Coggi G, Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res 1995;55:5049-53.
6. Ferrara N, Houck KA, Jakeman LB, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides [review]. J Cell Biochem 1991;47:211-8.
7. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
8. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993;53:4727-35.
9. Olson TA, Mohanraj D, Carson LF, Ramakrishnan S. Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res 1994;54:276-80.
10. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool [review]. J Clin Oncol 1995;13:765-82.
11. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1994;1221:211-4.
12. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, et al. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993;53:2912-8.
13. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, et al. Concentrations of vascular endothelial growth factor in sera of normal controls and cancer patients. Clin Cancer Res 1996;2:821-6.
14. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. American Joint Committee on Cancer. Manual for staging of cancer. 5th edition. Philadelphia: J. B. Lippincott, 1997.
15. Fiebich B, Jäger B, Schöllmann C, Weindel K, Wilting J, Kochs G, et al. Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. Eur J Biochem 1993;211:19-26.
16. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-9.
17. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Berse B, et al. Vascular permeability factor (VPF, VEGF) in tumor biology [review]. Cancer Metastasis Rev 1993;12:303-24.
18. Claffey KP, Brown LF, del Aguila LF, Tognazzi K, Yeo KT, Manseau EJ, et al. Expression of vascular permeability factor vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 1996;56:172-81.
19. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 1995;36: 193-204.
20. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 199dothelial growth factor in erythroderma [letter]. Lancet 1996;348: 1101.
21. Kraft A, Rössle M, Haag K, Berger E, Gastl G, Blum HE, et al. Vascular endothelial growth factor in advanced liver disease with or without malignancies [abstract]. Hepatology 1996; 320A.
22. Möhle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997;94: 663-8.
23. Yamamoto S, Konishi I, Kuroda H, Nanbu K, Sakahara H, Mori T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer 1997;75:1221-7.
24. Dirix LY, Vermeulen PB, Pawinski A, Prove A, De Pooter C, Martin M, et al. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 1997; 78:236-43.
25. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Dvorak HF, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-62.
26. Boocock CA, Charnock-Jones DS, Sharkey AM, McLaren J, Barker PJ, Wright KA, et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst 1995;87:506-16.
27. Paley PJ, Staskus KA, Gebhard K, Mohanraj D, Twiggs LB, Carson LF, et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997;80:98-106.
28. Berse B, Brown LF, Van de Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992;3:211-20.
29. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Sioussat TM, et al. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 1995;55:360-8.
30. Nagy JA, Morgan ES, Herzberg KT, Manseau EJ, Dvorak AM, Dvorak HF. Pathogenesis of ascites tumor growth: angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining. Cancer Res 1995;55:376-85.
31. Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab 1996;81: 353-9.
32. Moncayo HE, Penz-Koza A, Marth C, Gastl G, Herold M, Moncayo R. Studie über integrative Funktionen des Endokriniums, der Entzündungszytokine und Mitogene bei IVF. J Fertil Reprod 1997;7-12.
33. Krasnow JS, Zeleznik AJ, Berga SL, Yeo KT, Guzick DS. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil Steril 1996;65:552-5.
34. Perez RP, Godwin AK, Hamilton TC, Ozols RF. Ovarian cancer biology [review]. Semin Oncol 1991;18:186-204.
35. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.